Showing results (311-320 of 1,988) with videos related to

Sort By:
Pageof 199
Prostate Cancer and Prostatic Diseases|March 27, 2021
Hormone therapy use and the risk of acute kidney injury in patients with prostate cancer: a population-based cohort studyChris R Cardwell, Joe M O'Sullivan, Suneil Jain, et al.
Prostate Cancer and Prostatic Diseases|July 10, 2020
Ethnic variation in prostate cancer detection: a feasibility study for use of the Stockholm3 test in a multiethnic U.S. cohortHari T Vigneswaran, Andrea Discacciati, Peter H Gann, et al.
Prostate Cancer and Prostatic Diseases|August 8, 2020
Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institutionMatthew J Roberts, Alastair Macdonald, Sachinka Ranasinghe, et al.
Prostate Cancer and Prostatic Diseases|April 1, 2021
Preoperative 68Ga-PSMA PET/CT defines a subgroup of high-risk prostate cancer patients with favorable outcomes after radical prostatectomy and lymph node dissectionSnir Dekalo, Jonathan Kuten, Ishai Mintz, et al.
Prostate Cancer and Prostatic Diseases|April 14, 2021
A cross-sectional study on gut microbiota in prostate cancer patients with prostatectomy or androgen deprivation therapyJoseph K M Li, Lynn L Wang, Christine Y P Wong, et al.
Prostate Cancer and Prostatic Diseases|August 21, 2020
Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancerFelix Preisser, Giorgio Gandaglia, Farid Arad, et al.
Prostate Cancer and Prostatic Diseases|August 21, 2020
Treatment of metastatic castration resistant prostate cancer with radium-223: a retrospective study at a US tertiary oncology centerRana R McKay, Rebecca Silver, Rachel H Bhak, et al.
Prostate Cancer and Prostatic Diseases|August 23, 2020
Diagnostic ability of Ga-68 PSMA PET to detect dominant and non-dominant tumors, upgrading and adverse pathology in patients with PIRADS 4-5 index lesions undergoing radical prostatectomyErsin Koseoglu, Yakup Kordan, Mert Kilic, et al.
Prostate Cancer and Prostatic Diseases|July 12, 2020
Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysisZhigang Yuan, Daniel Fernandez, Jasreman Dhillon, et al.
Prostate Cancer and Prostatic Diseases|August 18, 2020
Risk of prostate cancer in men with HIV/AIDS: a systematic review and meta-analysisDianqin Sun, Maomao Cao, He Li, et al.
Pageof 199